ClinicalTrials.govpublic full text
The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use
rabies vaccine allergy, vaccination adverse event, anti-d antibodies, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804176
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.